Healthcare & Life Sciences
GAMAMABS
Francegamamabs.com/
GAMAMABS is a Healthcare & Life Sciences startup based in France, most recent round Series C+, 2 tracked investors.
Acquiredseries-c-plus
series-c-plus
Stage
2017
Founded
2
Investors
About GAMAMABS
Based in France, GAMAMABS is a startup founded in 2017. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
GAMAMABS is a French biotechnology company developing innovative antibody-drug conjugates (ADCs) for the treatment of cancer. Its lead product, GM-102, targets the tumor-associated antigen AMHR2 for ovarian and other solid tumors.
Explore GAMAMABS's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.